J. Yarnold

843 total citations
20 papers, 464 citations indexed

About

J. Yarnold is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, J. Yarnold has authored 20 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in J. Yarnold's work include Breast Cancer Treatment Studies (11 papers), Advanced Radiotherapy Techniques (6 papers) and Estrogen and related hormone effects (3 papers). J. Yarnold is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Advanced Radiotherapy Techniques (6 papers) and Estrogen and related hormone effects (3 papers). J. Yarnold collaborates with scholars based in United Kingdom, Canada and Sweden. J. Yarnold's co-authors include Reinhard Würm, N.G. Burnet, Jan Nyman, J.H. Peacock, Ingela Turesson, Nisha K. Duggal, Anthony Neal, W. Swindell, W. P. M. Mayles and Philip Evans and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

J. Yarnold

20 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Yarnold United Kingdom 9 233 218 144 128 122 20 464
Nicolas J. McNally United Kingdom 10 102 0.4× 174 0.8× 88 0.6× 47 0.4× 181 1.5× 14 338
Anna Morra Italy 13 381 1.6× 155 0.7× 254 1.8× 115 0.9× 107 0.9× 33 521
Elisa Bordón Spain 15 109 0.5× 169 0.8× 32 0.2× 172 1.3× 100 0.8× 20 450
Howard Liu Australia 13 80 0.3× 60 0.3× 57 0.4× 202 1.6× 198 1.6× 43 555
Xiushan Zheng China 11 222 1.0× 58 0.3× 29 0.2× 85 0.7× 94 0.8× 18 445
Jianxin Wang China 12 58 0.2× 67 0.3× 76 0.5× 62 0.5× 188 1.5× 30 351
R. Jeffery Karnes United States 9 64 0.3× 35 0.2× 75 0.5× 67 0.5× 302 2.5× 13 479
J.D. Forman United States 9 74 0.3× 33 0.2× 92 0.6× 102 0.8× 274 2.2× 23 358
I. Brown United Kingdom 8 50 0.2× 152 0.7× 30 0.2× 83 0.6× 70 0.6× 22 311
Lars Löfgren Sweden 10 181 0.8× 92 0.4× 9 0.1× 106 0.8× 42 0.3× 22 369

Countries citing papers authored by J. Yarnold

Since Specialization
Citations

This map shows the geographic impact of J. Yarnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Yarnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Yarnold more than expected).

Fields of papers citing papers by J. Yarnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Yarnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Yarnold. The network helps show where J. Yarnold may publish in the future.

Co-authorship network of co-authors of J. Yarnold

This figure shows the co-authorship network connecting the top 25 collaborators of J. Yarnold. A scholar is included among the top collaborators of J. Yarnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Yarnold. J. Yarnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurup, A., J. Pasternak, R. Taylor, et al.. (2019). Simulation of a radiobiology facility for the Centre for the Clinical Application of Particles. Physica Medica. 65. 21–28. 4 indexed citations
2.
Brunt, Adrian Murray, Joanne Haviland, Mark Sydenham, et al.. (2018). FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015). International Journal of Radiation Oncology*Biology*Physics. 102(5). 1603–1604. 34 indexed citations
3.
Bliss, Judith M., Peter Ellis, Lucy Kilburn, et al.. (2012). Abstract P1-13-03: Mature analysis of UK Taxotere as Adjuvant Chemotherapy (TACT) trial (CRUK 01/001); effects of treatment and characterisation of patterns of breast cancer relapse.. Cancer Research. 72(24_Supplement). P1–13. 4 indexed citations
4.
Haviland, Joanne, Mark Sydenham, J. Mills, et al.. (2012). OC-0135 CAN PATIENT REPORTED OUTCOME MEASURES REPLACE CLINICAL ASSESSMENTS IN BREAST RADIOTHERAPY TRIALS?. Radiotherapy and Oncology. 103. S53–S53. 4 indexed citations
5.
Campbell, Helen, David Epstein, David Bloomfield, et al.. (2011). The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer. 47(17). 2517–2530. 31 indexed citations
6.
Brunt, Adrian Murray, Mark Sydenham, Judith M. Bliss, et al.. (2009). 7LBA A 5-fraction regimen of adjuvant radiotherapy for women with early breast cancer: first analysis of the randomised UK FAST trial (ISRCTN62488883, CRUKE/04/015). European Journal of Cancer Supplements. 7(3). 2–2. 12 indexed citations
7.
Coles, C.E., et al.. (2008). Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery – audit on behalf of the IMPORT Trial Management Group. European Journal of Cancer Supplements. 6(7). 145–145. 3 indexed citations
8.
Coles, C.E., Gordon Wishart, E. Donovan, et al.. (2007). P15 The IMPORT Gold Seed Study: Evaluation of Tumour Bed Localisation and Image-guided Radiotherapy for Breast Cancer. Clinical Oncology. 19(3). S26–S27. 5 indexed citations
9.
Coles, C.E., J. Fairfoul, Ellen M. Donovan, et al.. (2007). O-17 Implanted gold seeds for tumour bed localisation and image-guided radiotherapy. European Journal of Cancer Supplements. 5(3). 6–6. 1 indexed citations
10.
Wheatley, Duncan, Asha Adwani, S. Ebbs, et al.. (2004). Matching supraclavicular fields to the extent of axillary surgery in women prescribed radiotherapy for early stage carcinoma of the breast. Clinical Oncology. 17(1). 32–38. 5 indexed citations
13.
Evans, Philip, et al.. (1995). Design of compensators for breast radiotherapy using electronic portal imaging. Radiotherapy and Oncology. 37(1). 43–54. 62 indexed citations
14.
Neal, Anthony & J. Yarnold. (1995). Estimating the volume of lung irradiated during tangential breast irradiation using the central lung distance. British Journal of Radiology. 68(813). 1004–1008. 29 indexed citations
15.
Burnet, N.G., Jan Nyman, Ingela Turesson, et al.. (1995). The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Medical dosimetry. 20(2). 143–144. 2 indexed citations
16.
Würm, Reinhard, et al.. (1994). Cellular radiosensitivity and dna damage in primary human fibroblasts. International Journal of Radiation Oncology*Biology*Physics. 30(3). 625–633. 77 indexed citations
17.
Jefferies, Sarah & J. Yarnold. (1994). Post-mastectomy radiotherapy: Is it cure after all?. European Journal of Cancer. 30(11). 1600–1601. 4 indexed citations
18.
Burnet, N.G., Reinhard Würm, J. Yarnold, et al.. (1992). Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. The Lancet. 339(8809). 1570–1571. 129 indexed citations
19.
Coombes, R. Charles, Douglas F. Easton, C E Chilvers, et al.. (1987). Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer.. PubMed. 47(9). 2494–7. 27 indexed citations
20.
Yarnold, J.. (1984). Selective avoidance of lymphatic irradiation in the conservative management of breast cancer. Radiotherapy and Oncology. 2(2). 79–92. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026